Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
International Journal of Cancer|September 20, 2023
Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell functionMasashi Funauchi, Satoshi Serada, Kosuke Hiramatsu, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2010
The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cellsMinoru Fujimoto, Mayumi Nakano, Fumitaka Terabe, et al.Proteomics. Clinical Applications|December 8, 2010
Proteomic analysis of autoantigens associated with systemic lupus erythematosus: Anti-aldolase A antibody as a potential marker of lupus nephritisSatoshi Serada, Minoru Fujimoto, Tsuyoshi Takahashi, et al.International Journal of Cancer|November 19, 2011
Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cellsYoshihito Souma, Toshirou Nishida, Satoshi Serada, et al.International Journal of Cancer|October 22, 2017
Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancerSatoko Matsuzaki, Satoshi Serada, Kosuke Hiramatsu, et al.International Journal of Cancer|June 26, 2012
Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancerTakuhei Yokoyama, Takayuki Enomoto, Satoshi Serada, et al.International Journal of Cancer|July 15, 2009
Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatinAyako Kim, Takayuki Enomoto, Satoshi Serada, et al.American Journal of Obstetrics and Gynecology|July 28, 2019
Copper ions are novel therapeutic agents for uterine leiomyosarcomaMamoru Kakuda, Shinya Matsuzaki, Yutaka Ueda, et al.Annals of the Rheumatic Diseases|October 27, 2009
iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseasesSatoshi Serada, Minoru Fujimoto, Atsushi Ogata, et al.Inflammatory Bowel Diseases|March 1, 2012
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitisSatoshi Serada, Minoru Fujimoto, Fumitaka Terabe, et al.Pageof 13